News

Amyotrophic lateral sclerosis, or Lou Gehrig's disease, causes progressive muscle weakening. Learn more here.
A new study links common mental health drugs to a higher ALS risk. The research focused on anxiolytics, hypnotics, and ...
The amount of lives that he touched and changed for the better number in the thousands," his stepdaughter wrote.
Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive neurological disorder that affects motor neurons in the brain and spinal cord .
BrainStorm Cell Therapeutics issued a statement Tuesday supporting a Citizens’ Petition submitted to the FDA requesting the ...
Doctors implanted a microchip into a paralyzed patient's brain as part of a clinical trial giving people the ability to ...
A Q&A with author and activist Mindy Uhrlaub, who shares how she is using her voice to raise awareness and support for the ...
Klotho is advancing its ALS gene therapy candidate KLTO‑202 to the manufacturing phase, and is planning the first human ...
Aging is the primary risk factor for neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis ...
Tech billionaire Elon Musk’s Neuralink is one of the most talked about players in the BCI field, but the first product to ...
Klotho Neurosciences moves forward with manufacturing gene therapy to treat amyotrophic lateral sclerosis: New York Tuesday, July 1, 2025, 15:00 Hrs [IST] Klotho Neurosciences, In ...
Experimental drug Ulefnersen offers hope for rare, early-onset Amyotrophic lateral sclerosis (ALS) in clinical trials.